Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coxiella burnetii is a small, Gram-negative, pleomorphic, obligately intracellular bacterium of the class Gammaproteobacteria, order Legionellales. It is the etiological agent of Q fever, causing both acute and chronic infections in humans and animals. The bacterium primarily infects monocytes/macrophages and replicates within a specialized vacuole resembling a phagolysosome. It has a biphasic life cycle with environmentally resistant small cell variants and metabolically active large cell variants. Disease transmission typically occurs via aerosolized particles from infected animals or animal products. Because of its very low infectious dose, environmental stability, and potential for airborne spread, C. burnetii is considered a possible agent of bioterrorism. Treatment relies on prolonged antibiotic regimens, often with doxycycline and hydroxychloroquine, and preventive vaccination is available but limited by strong reactogenicity in previously sensitized individuals.
Antibiotics: Inhibit bacterial protein synthesis or DNA replication (e.g., doxycycline inhibits the 30S ribosomal subunit, rifampin inhibits RNA polymerase). Host-directed drugs: Alter host cell signaling or immune responses to inhibit bacterial replication (not direct action on the bacterium itself).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coxiella burnetii (C. burnetii).